Home LiteratureArticle Details
PMID: 11376134 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms.

Molecular pathology : MP ·Vol. 54 ·No. 3 ·2001-06-00 ·Pages 192-6

Blom IE, van Dijk AJ, de Weger RA, Tilanus MG, Goldschmeding R

Abstract

Connective tissue growth factor (CCN2; CTGF) is a newly identified growth factor, which is involved in the regulation of wound repair and fibrosis. Because there is variation among individuals with respect to tissue response to injury, genetic factors might be involved in the final outcome of tissue repair or scarring. For example, polymorphisms in the promoter region of genes, such as those encoding transforming growth factor beta1 (TGF-beta1), interleukin 10 (IL-10), and tumour necrosis factor alpha (TNF-alpha), influence transcriptional responses and are thought to contribute to the dysregulation of these genes in pathological conditions. To investigate whether the promoter region of the ccn2 (ctgf) gene contains polymorphic sequences that might account for differential expression. Seventy seven human DNA samples were sequenced-45 were from healthy controls and 32 were from patients with ischaemic heart disease (IHD)-using M13 tailed sequence specific ccn2 (ctgf) primers for amplification of a 600 bp fragment upstream of the transcription start site. Amplicons were bidirectionally sequenced with a dye primer M13 forward and reverse sequencing kit. A C to G substitution was identified at position -132 in one of the patients with IHD. Moreover, in five of the 32 patients with IHD and in six of the 45 healthy controls, a G to C polymorphism was found at position -447. These substitutions at -132 and -447 are thought to lie within predicted binding domains for the transcription factors Pbx-1 and MZF1, respectively. In addition, insertions at position -43 (G), -47 (C), -71 (G) and a C to T substitution at position -198 were found in all DNA samples compared with the published ccn2 (ctgf) promoter sequence. These corrections do not involve sequences predicted to function as transcription factor binding sites. Sequence analysis of the ccn2 (ctgf) promoter of 77 human DNA samples has revealed corrections and polymorphic sites. The latter lie within putative regulatory elements.

MeSH Terms
Alleles Amino Acid Substitution/genetics Binding Sites Case-Control Studies Connective Tissue Growth Factor Genotype Growth Substances/genetics Humans Immediate-Early Proteins/genetics Intercellular Signaling Peptides and Proteins Myocardial Ischemia/genetics Polymorphism, Genetic Promoter Regions, Genetic Sequence Analysis, DNA Software Transcription Factors/genetics
Chemicals
CCN2 protein, human Growth Substances Immediate-Early Proteins Intercellular Signaling Peptides and Proteins Transcription Factors Connective Tissue Growth Factor
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Blom I E
Department of Pathology, H04.312, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
van Dijk A J
de Weger R A
Tilanus M G
Goldschmeding R
References (33)
33 references, click to expand
  1. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells.
    J Biol Chem. 1999 Feb 26;274(9):5830-4 PMID: 10026205
  2. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation.
    Transplantation. 1998 Oct 27;66(8):1014-20 PMID: 9808485
  3. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model.
    J Cell Physiol. 1999 Oct;181(1):153-9 PMID: 10457363
  4. Expression of connective tissue growth factor in experimental rat and human liver fibrosis.
    Hepatology. 1999 Oct;30(4):968-76 PMID: 10498649
  5. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.
    N Engl J Med. 1999 Oct 21;341(17):1264-9 PMID: 10528036
  6. Cytokine gene polymorphism in human disease: on-line databases.
    Genes Immun. 1999 Sep;1(1):3-19 PMID: 11197303
  7. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.
    J Biol Chem. 2001 Apr 6;276(14):10594-601 PMID: 11152469
  8. Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic.
    Cancer Res. 1995 Aug 15;55(16):3610-4 PMID: 7627970
  9. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders.
    J Invest Dermatol. 1996 Apr;106(4):729-33 PMID: 8618012
  10. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene.
    Cell Growth Differ. 1996 Apr;7(4):469-80 PMID: 9052988
  11. Pbx-1 Hox heterodimers bind DNA on inseparable half-sites that permit intrinsic DNA binding specificity of the Hox partner at nucleotides 3' to a TAAT motif.
    Nucleic Acids Res. 1996 Jun 15;24(12):2288-94 PMID: 8710498
  12. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor.
    J Invest Dermatol. 1996 Sep;107(3):404-11 PMID: 8751978
  13. Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway.
    Cell Growth Differ. 1997 Jan;8(1):61-8 PMID: 8993835
  14. TRANSFAC: an integrated system for gene expression regulation.
    Nucleic Acids Res. 2000 Jan 1;28(1):316-9 PMID: 10592259
  15. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
    J Am Soc Nephrol. 2000 Jan;11(1):25-38 PMID: 10616837
  16. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction.
    J Biol Chem. 2000 May 12;275(19):14632-41 PMID: 10799550
  17. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts.
    J Biol Chem. 2000 May 19;275(20):15220-5 PMID: 10809757
  18. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells.
    J Hepatol. 2000 May;32(5):754-61 PMID: 10845662
  19. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.
    Exp Cell Res. 2000 Aug 25;259(1):213-24 PMID: 10942593
  20. Connective tissue growth factor in human liver cirrhosis.
    Liver. 2000 Jul;20(4):296-304 PMID: 10959808
  21. Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis.
    Kidney Int. 2000 Oct;58(4):1389-99 PMID: 11012874
  22. CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.
    J Mol Cell Cardiol. 2000 Oct;32(10):1805-19 PMID: 11013125
  23. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1.
    J Biol Chem. 2000 Nov 10;275(45):35584-91 PMID: 10952976
  24. Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton.
    J Biol Chem. 2000 Dec 1;275(48):37429-35 PMID: 10976101
  25. Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation.
    Cytokine. 2000 Dec;12(12):1778-83 PMID: 11097747
  26. An investigation of polymorphism in the interleukin-10 gene promoter.
    Eur J Immunogenet. 1997 Feb;24(1):1-8 PMID: 9043871
  27. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions.
    Circulation. 1997 Feb 18;95(4):831-9 PMID: 9054739
  28. Combinatorial signaling by Twisted Gastrulation and Decapentaplegic.
    Mech Dev. 1997 Jun;64(1-2):61-75 PMID: 9232597
  29. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts.
    Cytokine Growth Factor Rev. 1997 Sep;8(3):171-9 PMID: 9462483
  30. Expression of connective tissue growth factor in human renal fibrosis.
    Kidney Int. 1998 Apr;53(4):853-61 PMID: 9551391
  31. Dexamethasone is a novel potent inducer of connective tissue growth factor expression. Implications for glucocorticoid therapy.
    J Biol Chem. 1998 Jul 17;273(29):18185-90 PMID: 9660779
  32. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis.
    Am J Physiol. 1998 Aug;275(2 Pt 1):L365-71 PMID: 9700098
  33. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis.
    Ann Surg. 1999 Jul;230(1):63-71 PMID: 10400038
Article Info
Journal
Molecular pathology : MP
Abbr.
Mol Pathol
ISSN
1366-8714
Published
2001-06-00
Pages
192-6
Language
English
Region
England
NLM ID
9706282
PMCID
PMC1187061
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]